Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro 5mg is not a starter pen — it is the second strength in the tirzepatide schedule, reached after at least four weeks on 2.5mg. If you are searching for a 5mg offer, you are almost certainly asking one of two things: whether you can jump straight to this dose, or whether a cheaper deal exists somewhere. Both are reasonable questions. Mounjaro is a prescription-only medicine, so any legitimate supply requires a clinical assessment by a prescriber first, regardless of the dose or the price attached to it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro titration schedule exists for a reason. The 2.5mg pen is designed to let your body adjust to tirzepatide before the medicine starts doing its main job. Four weeks in, a prescriber will typically move patients to 5mg, and this is the point where most people begin to notice a meaningful shift in appetite and fullness. The step-up is not just a number change on the pen; the 5mg dose is where tirzepatide begins to produce the metabolic effects that the clinical trials were built around.
A question our prescribers hear most weeks is whether someone can start at 5mg to get results faster. The answer is no, and the reason is straightforward: beginning at a higher dose significantly increases the likelihood of nausea, vomiting and other gastrointestinal side effects. The schedule exists to protect you from an unpleasant early experience that might cause you to stop treatment entirely. You can read more about how the 5mg dose fits into the broader treatment journey and what to expect once you reach it.
If you are currently on 2.5mg and approaching your four-week mark, your prescriber will assess whether a step to 5mg is appropriate based on how you have tolerated the starter pen. That decision belongs with a clinician, not a countdown timer.
Short answer: no, not in the way that word is usually used online. Mounjaro is a prescription-only medicine. The MHRA's guidance is clear that GLP-1 medicines are not assessed for cosmetic or quick weight loss, and UK law prohibits the advertising of POMs to the public with promotional intent. That means any seller offering Mounjaro 5mg at a suspiciously reduced price, bundled with a voucher code, or available without going through a proper clinical assessment, is operating outside the rules.
Eli Lilly raised Mounjaro's UK list price substantially from September 2025, with typical private prices now ranging roughly £149 to £375 per month depending on dose and provider. The UK cost picture for Mounjaro is worth understanding before you commit to any provider, including what headline prices do and do not include. Some quotes omit the consultation fee, the prescription charge, or aftercare, so the apparent saving evaporates on closer inspection. If you want to understand what current Mounjaro 5mg pricing and availability looks like through legitimate regulated channels, that page sets out what you can realistically expect.
The MHRA has warned repeatedly about counterfeit weight-loss pens sold through social media and unofficial channels. In 2025, around 20 million doses of illegally traded weight-loss medicines (estimated street value ~£45 million) were seized, and a site producing fake tirzepatide pens was raided in the UK. A rock-bottom price is a red flag, not a bargain. Suspect sellers can be reported at the MHRA's Yellow Card scheme.
Suitability for Mounjaro at any dose starts with the licensed criteria: adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes, prediabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. BMI alone does not determine approval, the prescriber reviews your full health picture.
Reaching 5mg specifically requires that you have completed at least four weeks on 2.5mg and that your prescriber is satisfied with how you have tolerated it. Transfer patients moving from another provider need to provide evidence of their current dose and treatment history. People who are pregnant, trying to conceive, or breastfeeding should not use Mounjaro; it is also not licensed for under-18s. Certain conditions, including a personal or family history of medullary thyroid carcinoma, require discussion with a prescriber before treatment begins.
For a broader picture of who Mounjaro is licensed for in the UK, the Mounjaro treatment overview covers eligibility in detail alongside the clinical evidence. If you are earlier in your research, the 2.5mg starter pen page explains what the first four weeks typically look like.
The legal route is a prescription following clinical assessment, that applies regardless of which dose you need or where you choose to get it. Any online pharmacy supplying Mounjaro should be verifiable on the GPhC register at pharmacyregulation.org/registers; if it is not listed, do not use it.
At nume, the process is straightforward. You complete a free consultation, which is read the same day by a GPhC-registered Independent Prescriber, a real clinician, not automated software. Identity is verified by photo ID, and weight is confirmed on a video call. If treatment is clinically suitable and you order before midday Monday to Friday, your pen is dispatched the same day and arrives free the next working day via DPD, in plain unbranded packaging.
Repeat orders are clinically re-reviewed before dispatch, there are no automatic renewals. Dose increases to 5mg require evidence that 2.5mg has been tolerated; this is standard clinical practice, not bureaucracy. Patients progressing beyond 5mg can find out more about what the tirzepatide 10mg stage involves and how that step-up is managed clinically. Our clinical team page sets out the prescriber oversight behind every consultation. If you have questions before starting, the FAQs cover the most common ones.
When you are ready to find out whether Mounjaro is appropriate for you, the right starting point is a clinical conversation rather than a price comparison. Check your eligibility with a free consultation and let a prescriber help you work out the right dose and the right pace.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.